880 related articles for article (PubMed ID: 22989573)
1. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
[TBL] [Abstract][Full Text] [Related]
2. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.
Ruíz-del-Árbol L; Achécar L; Serradilla R; Rodríguez-Gandía MÁ; Rivero M; Garrido E; Natcher JJ
Hepatology; 2013 Nov; 58(5):1732-41. PubMed ID: 23703953
[TBL] [Abstract][Full Text] [Related]
3. Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.
Kalambokis G; Christaki M; Tsiakas I; Despotis G; Lakkas L; Tsiouris S; Xourgia X; Markopoulos GS; Dova L; Milionis H
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):775-783. PubMed ID: 38526935
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
6. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
Wong F; Liu P; Lilly L; Bomzon A; Blendis L
Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
[TBL] [Abstract][Full Text] [Related]
7. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
8. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
9. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
[TBL] [Abstract][Full Text] [Related]
10. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
Wong F; Raina N; Richardson R
Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
Solà E; Ginès P
Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
[TBL] [Abstract][Full Text] [Related]
12. Circulatory function and hepatorenal syndrome in cirrhosis.
Ruiz-del-Arbol L; Monescillo A; Arocena C; Valer P; Ginès P; Moreira V; Milicua JM; Jiménez W; Arroyo V
Hepatology; 2005 Aug; 42(2):439-47. PubMed ID: 15977202
[TBL] [Abstract][Full Text] [Related]
13. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
Arroyo V; Jiménez W
J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic evaluation of systolic and diastolic left ventricular function following arterial switch operation in the neonatal period for transposition of the great arteries. Midterm results.
Crepaz R; Secchieri S; Svaluto G; Milanesi O; Pitscheider W; Gentili L; Rubino M; Stellin G
G Ital Cardiol; 1997 Mar; 27(3):224-30. PubMed ID: 9199950
[TBL] [Abstract][Full Text] [Related]
16. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
Téllez L; Ibáñez-Samaniego L; Pérez Del Villar C; Yotti R; Martínez J; Carrión L; Rodríguez de Santiago E; Rivera M; González-Mansilla A; Pastor Ó; Bermejo J; Bañares R; Albillos A
J Hepatol; 2020 Dec; 73(6):1404-1414. PubMed ID: 32446716
[TBL] [Abstract][Full Text] [Related]
17. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study.
Sampaio F; Pimenta J; Bettencourt N; Fontes-Carvalho R; Silva AP; Valente J; Bettencourt P; Fraga J; Gama V
Liver Int; 2013 Sep; 33(8):1158-65. PubMed ID: 23617332
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of Hepatorenal Syndrome.
Velez JCQ; Latt N; Rodby RA
Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
[TBL] [Abstract][Full Text] [Related]
20. Fluid retention in cirrhosis: pathophysiology and management.
Kashani A; Landaverde C; Medici V; Rossaro L
QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
